loader image
Saturday, February 7, 2026
69.4 F
McAllen
- Advertisement -

TMB President Zaafran Provides COVID-19 Update at August Board Meeting

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

Texas Medical Board President Dr. Sherif Z. Zaafran, M.D., provided an update on the Board’s ongoing COVID-19 response at today’s August board meeting. President Zaafran outlined ongoing agency efforts, reiterating the Board’s commitment in carrying out its vital mission of protecting public health during the pandemic. 

To date, TMB has issued over 2,700 emergency licenses and re-activated licenses for 55 retired licensees. “Our incredible staff has managed to issue or reactivate these licenses in a mere 1 to 3 business days,” said President Zaafran. “Importantly, this is work is being done concurrently with the Board’s existing, steady workload of processing thousands of other health care professionals to work in our state during this critical time.” 

In addition to increasing the number of available health care professionals through expediting emergency licensing, the Board has also worked with the Governor’s Office to help expand the use of telemedicine and relieve administrative requirements of licensees by extending deadlines for licensure renewals and in-person continuing medical education. 

- Advertisement -

During his board meeting update, President Zaafran also addressed misinformation regarding the Board’s previous statement on COVID-19 treatments. 

“The Texas Medical Board has never prohibited the use of Hydroxychloroquine alone, or in conjunction with other drugs, for the treatment of COVID-19. In fact, the TMB does not prohibit any drug or treatment,” clarified Zaafran. “The off-label use of Hydroxychloroquine as an alternative therapy for COVID-19 patients is completely permissible. As is the case with any alternative therapy, physicians must ensure they comply with Board Rule 200 which requires physicians to provide full disclosure of treatment options, side effects, and obtain informed consent.” 

“Licensees should not fear disciplinary action from the TMB simply for expressing their support of specific COVID-19 treatments like Hydroxychloroquine,” added Zaafran. “What providers should keep in mind is because there is no definitive cure, claims of a cure may constitute false, misleading or deceptive advertising, which is prohibited by law and may prompt an inquiry from the TMB.” 

“We at the TMB are very grateful for the incredible work performed by over one-hundred-fifty thousand TMB licensees to take care of our families, our neighbors, our fellow Texans, and us,” said Zaafran. “For as long as this pandemic persists and well beyond COVID-19, TMB staff and Board members will continue to efficiently and fairly serve our licensees and the citizens of Texas.” 

- Advertisement -

TMB will continue to provide any updates on COVID-19 issues on the TMB website at www.tmb.state.tx.us/page/coronavirus.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Strengthens Heart Health Resources for Families Across the RGV

Did you know that heart disease is one of the leading causes of death in the United States and that the Hispanic population faces a higher risk due to the high rates of blood pressure, high cholesterol, diabetes and obesity?

STHS Heart Celebrates 650th Robotic-Assisted Surgery

Mega Doctor News Since opening 30 years ago as one of the...

Food Safety Tips for a Healthy Super Bowl Sunday

Super Bowl parties often feature takeout, delivery and foods that are served over several hours. To help prevent foodborne illness, the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) is reminding fans to keep food safety in play on game day.

Houston Doctor Accused of Manipulating Medical Records to Block Patients from Transplants

A 66-year-old Houston physician has been charged with falsifying medical records which made potential transplant recipients ineligible for organ donations.
- Advertisement -
×